Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

CVS Health Corp (NY: CVS )

55.81 -0.65 (-1.15%)
Official Closing Price Updated: 7:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CVS Health Corp

< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Walgreens Mulls Bond Sale As JPMorgan Gauges Investor Appetite: Report
JP Morgan Chase is reportedly gauging investor interest in a possible issuance of high-yield bonds by Walgreens Boots Alliance, aimed at managing the drug-store chain's recently downgraded near-term... 
Via Benzinga
Topics Bonds
Exposures Debt Markets
3 Retail Stocks to Buy on the Dip: July 2024
These three retail stocks experienced recent dips and now offer attractive entry points with strong cases for investment. 
Via InvestorPlace
A Closer Look at CVS Health's Options Market Dynamics
Via Benzinga
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
Deep Dive Into CVS Health Stock: Analyst Perspectives (15 Ratings)
Via Benzinga
Market Whales and Their Recent Bets on CVS Options
Via Benzinga
CVS Class Action Alert: Robbins LLP Reminds Stockholders of the Lead Plaintiff Deadline in the CVS Health Corporation Class Action Lawsuit
From Robbins LLP
Via GlobeNewswire
3 Drone Delivery Stocks Ready for Takeoff
Drone delivery stocks are poised for takeoff, promising faster, safer and more efficient delivery solutions, reshaping logistics and retail. 
Via InvestorPlace
2 Beaten-Down Dividend Stocks With Ultra-High Yields Above 9%: Are They Bargains Now?
Find out if the huge yields these pressured dividend payers offer could be worth the risk. 
Via The Motley Fool
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against CVS and Walgreens and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
CVS HEALTH CORPORATION (NYSE: CVS) DEADLINE ALERT: Bernstein Liebhard LLP Reminds CVS Health Corporation Investors of Upcoming Deadline
From Bernstein Liebhard LLP
Via GlobeNewswire
CVS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that CVS Health Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CVS Health Corporation (CVS)
From Glancy Prongay & Murray LLP
Via Business Wire
AbbVie Could Soar 24%, According to a Wall Street Analyst. Is the High-Yield Dividend Stock a Buy Now?
The big pharma company's top drug is losing ground, but its dividend keeps rising. 
Via The Motley Fool
CVS INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that CVS Health Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
CVS Health Corporation Investor Notice: Robbins LLP Reminds Shareholders of the Class Action Filed Against CVS
From Robbins LLP
Via Business Wire
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against CVS Health Corporation (CVS)
From Law Offices of Howard G. Smith
Via Business Wire
The Law Offices of Frank R. Cruz Announces the Filing of a Securities Class Action on Behalf of CVS Health Corporation (CVS) Investors
From The Law Offices of Frank R. Cruz
Via Business Wire
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of CVS Health Corporation (CVS) Investors
From Glancy Prongay & Murray LLP
Via Business Wire
CVS ALERT: Bragar Eagel & Squire, P.C. Announces that a Class Action Lawsuit Has Been Filed Against CVS Health Corporation and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of CVS Health Corporation (CVS) Investors
From Law Offices of Howard G. Smith
Via Business Wire
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit with the Schall Law Firm
From Schall Law
Via GlobeNewswire
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages CVS Health Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – CVS
From The Rosen Law Firm PA
Via GlobeNewswire
Shareholder Alert: Robbins LLP Informs Stockholders of the Class Action Filed Against CVS Health Corporation (CVS)
From Robbins LLP
Via GlobeNewswire
CVS Investors Have Opportunity to Lead CVS Health Corporation Securities Fraud Lawsuit with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
CVS INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces That CVS Health Corporation Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit
From Robbins Geller Rudman & Dowd LLP
Via Business Wire
CVS HEALTH CORPORATION (NYSE: CVS) INVESTOR ALERT: Investors With Large Losses in CVS Health Corporation Should Contact Bernstein Liebhard LLP To Discuss Their Rights
From Bernstein Liebhard LLP
Via GlobeNewswire
CVS INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that CVS Health Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Wall Street's Most Accurate Analysts Say Buy These 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Rosen Law Firm Urges CVS Health Corporation (NYSE: CVS) Stockholders with Large Losses to Contact the Firm for Information About Their Rights
From The Rosen Law Firm, P.A.
Via Business Wire
< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.